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Abstract 
Background: The cohesin complex consists of multiple core subunits that play critical roles in mitosis and transcrip‑
tional regulation. The cohesin‑associated protein Wapal plays a central role in off‑loading cohesin to facilitate sister 
chromatid separation, but its role in regulating mammalian gene expression is not understood. We used embryonic 
stem cells as a model, given that the well‑defined transcriptional regulatory circuits were established through master 
transcription factors and epigenetic pathways that regulate their ability to maintain a pluripotent state.
Results: RNAi‑mediated depletion of Wapal causes a loss of pluripotency, phenocopying loss of core cohesin subu‑
nits. Using chromatin immunoprecipitation coupled with next‑generation sequencing (ChIP‑seq), we determine that 
Wapal occupies genomic sites distal to genes in combination with CTCF and core cohesin subunits such as Rad21. 
Interestingly, genomic sites occupied by Wapal appear enriched for cohesin, implying that Wapal does not off‑load 
cohesin at regions it occupies. Wapal depletion induces derepression of Polycomb group (PcG) target genes without 
altering total levels of Polycomb‑mediated histone modifications, implying that PcG enzymatic activity is preserved. 
By integrating ChIP‑seq and gene expression changes data, we identify that Wapal binding is enriched at the promot‑
ers of PcG‑silenced genes and is required for proper Polycomb repressive complex 2 (PRC2) recruitment. Lastly, we 
demonstrate that Wapal is required for the interaction of a distal cis‑regulatory element (CRE) with the c‑Fos promoter.
Conclusions: Collectively, this work indicates that Wapal plays a critical role in silencing of PcG target genes through 
the interaction of distal CREs with promoters.
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Background
Gene expression is regulated by the complex interplay 
of cis-acting DNA elements and trans acting molecules 
such as transcription factors (TFs). The cohesin com-
plex plays a critical role in connecting distal cis-acting 
DNA elements to gene promoters by facilitating DNA 
loops [1–3]. In addition, the cohesin complex mediates 
sister chromatid cohesion during mitosis, ensuring 
proper genomic segregation [4]. In mitosis, the core 
cohesin subunits Smc1a, Smc3, and Rad21 are loaded 
onto sister chromatids by Nipbl in early G1/late telo-
phase and off-loaded starting in prophase by Wapal [5, 6]. 
While the function of core cohesin subunits and acces-
sory proteins (Nipbl, Wapal) are well established during 
mitosis, Wapal’s role during transcriptional regulation 
remains less well defined. The core cohesin subunits 
facilitate interactions between genes and distal cis-reg-
ulatory elements by “looping-out” the intervening chro-
matin segment [2–4, 7]. In embryonic stem cells (ESCs), 
the majority of cohesin-binding sites are co-occupied 
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by CTCF, but a minority of cohesin-binding sites rep-
resent transcriptional enhancers [2, 8–10]. Depletion of 
cohesin core subunits by RNA interferences (RNAi) in 
ESCs causes differentiation secondary to either transcrip-
tional or cell-cycle changes [2, 8, 11]. Whether Wapal 
participates in gene regulation through facilitating DNA 
loops or even binds to specific genomic regions remains 
unknown. However, recent studies indicate Wapal plays a 
role during interphase through controlling the dynamic 
association of cohesin with chromatin [12, 13]. However, 
because the precise genomic sites occupied by Wapal are 
unknown, it is difficult to know its precise role in regulat-
ing cohesin’s association with specific chromatin regions.
Given the critical role of cohesin in mitosis, mutations 
within core subunits would be expected to cause signifi-
cant mitotic defect(s). A subset of patients with Cornelia 
de Lange Syndrome (CdLS), characterized by microceph-
aly, cognitive impairment, abnormal facies, and other 
malformations has mutations within core subunits of 
the cohesin complex including Smc1a, Smc3, and Rad21 
(reviewed in [14, 15]. However, these patients have spo-
radic heterozygous mutations, implying that complete 
loss of cohesin activity through null mutations is incom-
patible with life. Given that these mutations behave in an 
autosomal dominant fashion with unaffected parents, it 
implies that the majority of CdLS mutations occur within 
the parental germ cells. Surprisingly, CdLS patient sam-
ples exhibit a normal cell cycle, implying that cohesin 
haploinsufficiency does not cause CdLS through altera-
tions in mitosis. Recent work has also demonstrated 
that heterozygous mutations in cohesin are a common 
(5–20  %) occurrence in patients with acute myeloid 
leukemia (AML) and related disorders [16, 17]. Given 
that AML samples rarely exhibit significant changes in 
chromosomal number, it again highlights that cohesin 
mutations likely cause disease by alterations in gene 
expression.
Compared to the core cohesin subunits, far less is 
known about the role of Wapal in transcriptional regu-
lation. In mammals, Wapal plays a role in off-loading 
cohesin to prevent chromatin condensation [13], imply-
ing that Wapal likely antagonizes core cohesin subunits 
during transcriptional regulation. However, because the 
specific genomic sites occupied by Wapal are unknown, 
its precise role in mammalian transcriptional regula-
tion remains unclear. In Drosophila, Wapal promotes 
Polycomb group silencing, although the mechanism is 
unclear and whether it applies to mammals is unknown 
[12].
How Polycomb complexes are targeted to specific 
genomic regions remains a critical question within epi-
genetics given their important role in cellular differentia-
tion [18]. In Drosophila, Polycomb targeting is mediated 
by specific distal cis-regulatory elements (CREs) termed 
Polycomb response elements (PREs) [18, 19]. In con-
trast, mammalian PREs are rare [19], and other proposed 
mechanisms for PcG targeting include noncoding RNAs 
[20], nonspecific silencing of all transcription which must 
be subsequently relieved by transcriptional activators 
[21], interactions with other sequence-specific DNA-
binding proteins such as CTCF [22, 23], or the presence 
of CpG islands within the promoter. Collectively, the 
diversity of proposed targeting mechanisms illustrates 
the lack of consensus within the field.
To better delineate the role of Wapal in mammalian 
transcriptional regulation, we have chosen murine ESCs 
as a model system. ESCs are unique because they possess 
two critical properties: pluripotency, or the ability to dif-
ferentiate into all three primitive germ layers (mesoderm, 
ectoderm, and endoderm) that give rise to the embryo, 
and self-renewal, or the ability to propagate indefi-
nitely in an undifferentiated state. The transcriptional 
and epigenetic pathways that regulate both functions 
have been well defined through a series of genome-wide 
approaches. Our study demonstrates that Wapal plays 
a central role in regulating transcription by assisting in 
Polycomb group-mediated gene silencing.
Results
Wapal depletion causes ESCs to differentiate
Depletion of cohesin complex core subunits (Smc3, 
Smc1a, Scc1/Rad21) causes a loss of pluripotency when 
depleted in ESCs [2, 8, 11]. To examine whether loss of 
Wapal had a similar effect, we depleted Wapal in ESCs 
using RNAi. We infected ESCs with puromycin-resist-
ance-encoding lentiviruses containing short-hairpin 
RNAs (shRNAs) to deplete Wapal. As a positive con-
trol, we depleted the pluripotency TF Sall4 with a single 
shRNA; a second shRNA to Sall4 gives similar results [24, 
25]. Depletion of both Wapal and Sall4 induced a loss of 
compact, spherical colonies indicative of differentiation 
6 days after infection (Fig. 1a, top panels). Surface expres-
sion of the pluripotency marker alkaline phosphatase was 
partially reduced and highlights the significant morpho-
logical changes that occurred following Wapal deple-
tion (Fig.  1a, bottom panels). To quantitate the changes 
in pluripotency, we used Cas9-mediated genomic edit-
ing to create an ESC line with an internal ribosomal 
entry site:enhanced green fluorescent protein reporter 
(IRES:EGFP) cassette inserted into the Oct4 locus, allow-
ing EGFP expression to be a surrogate marker for pluri-
potency. The same approach has been used to generate 
a flow cytometry-based assay to quantitate changes in 
pluripotency [26, 27]. After 6  days of puromycin selec-
tion, we observed a statistically significant reduction in 
the mean fluorescent intensity (MFI) of the GFP peak 
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after depleting with shRNAs to Sall4 or Wapal (shRNA 
#2, Additional file 1: Figure S1a). Wapal shRNA #1 caused 
a reduction in the MFI but did not reach statistical sig-
nificance (p value <0.08). Taken together, the changes in 
cell morphology and alkaline phosphatase activity and 
decrease in Oct4:IRES:EGFP expression indicate that 
Wapal depletion induces a loss of pluripotency and sub-
sequent differentiation of ESCs. Similar results have been 
observed by other groups when depleting Smc3, Smc1a 
[2], or Rad21 [8], indicating that depletion of Wapal 
phenocopies the loss of core cohesin subunits on ESC 
pluripotency.
We further examined the effects of each shRNA on 
known pluripotency markers (Fig.  1b). Both shRNAs 
induced a strong knockdown of Wapal by greater than 
80  %. Wapal knockdown was associated with a signifi-
cant reduction in the expression of pluripotency mark-













































































































































Fig. 1 a ESCs were infected with lentiviruses encoding shRNAs to Sall4 and Wapal. Cells with a high multiplicity of infection (MOI) were selected 
by addition of puromycin for 6 days. Images were taken by bright field (BF, ×10) or after staining for the pluripotency marker alkaline phosphatase 
(AP, ×10). b Changes in pluripotency markers (Nanog, Oct4, Sall4, and Rex1) and Wapal were measured by RT‑qPCR. Fold change was calculated 
relatively to cells infected with the empty vector and plotted linearly on the y‑axis. Error bars represent SEM of at least two experiments. Asterisk 
indicates statistically significant reductions compared to empty vector (p value <0.05). c Similar to b, but for differentiation markers Brachyury 
(mesoderm), Fgf5 (ectoderm), and Cdx2 (trophectoderm). a Log10 scale for fold change is used because of strong induction of these markers. 
Asterisk indicates statistically significant increases compared to empty vector (p value <0.05). d Protein levels after depletion of Wapal or Sall4 for 
core cohesin subunits Rad21 and Smc3. GAPDH is shown as a loading control. Intervening, unrelated lanes were removed, but all samples were run 
on the same gel. e Propidium iodide (PI) staining was used to measure DNA levels in cells by flow cytometry. The percent of cells within each phase 
of the cell cycle and which exhibited abnormal DNA content (<2N or >4N) is shown. The only statistically significant difference was in the fraction 
within G0/G1 after depletion of Sall4 or Wapal as compared to empty vector (asterisk indicates p value <0.05)
Page 4 of 18Stelloh et al. Epigenetics & Chromatin  (2016) 9:14 
differentiation markers are increased in expression after 
Wapal depletion, we screened a panel of lineage-specific 
markers including Cdx2 (trophectoderm), Brachyury 
(mesoderm), and Fgf5 (ectoderm). As shown in Fig.  1c, 
depletion of Wapal is associated with a dramatic increase 
in each marker, indicating differentiation into these lin-
eages. Collectively, these data indicate that Wapal is 
required for ESC pluripotency. To determine whether 
Wapal depletion induces differentiation through indi-
rect effects on other members of the cohesin completion, 
we performed Western blots to assess the levels of two 
core subunits of the cohesin complex, Rad21 and Smc3 
(Fig. 1d). Wapal depletion had minimal effect on Rad21 
or Smc3 protein levels, indicating that the loss of pluripo-
tency is unlikely to be secondary to altered expression of 
other core cohesin subunits.
Given the role of Wapal in off-loading cohesin from 
sister chromatids at the end of mitosis, we assessed the 
cell cycle to determine whether Wapal depletion induced 
aneuploidy, which could cause a loss of pluripotency. We 
measured DNA content by propidium iodide (PI) stain-
ing in ESCs 48 h after Wapal depletion and assessed the 
percent of cells in different stages of the cell cycle or that 
exhibited aneuploidy (Fig. 1e). We chose an earlier time 
point than our differentiation experiments because sub-
tle changes in the cell cycle early in the process could be 
responsible for differentiation. Depletion of neither the 
pluripotency TF Sall4 nor Wapal increased the number 
of aneuploid cells. We saw a slight increase in the number 
of cells in G0/G1 when we depleted either Sall4 or Wapal, 
but little change in the percentage of cells in M or S 
phase. Collectively, these data indicate that Wapal deple-
tion does not dramatically alter the cell cycle or promote 
aneuploidy in ESCs. Thus, the loss of pluripotency is 
unlikely to be caused by a mitotic defect or aneuploidy.
To ensure that the pluripotency changes were not sec-
ondary to off-target effects of our shRNAs, we generated 
an ESC line expressing an epitope (v5)-tagged version 
of full-length Wapal immune to shRNA #2 by mutating 
every third base in each codon within the shRNA rec-
ognition site. This strategy prevents recognition by the 
shRNA without altering the linear amino acid sequence. 
Infection with shRNA #2 on wild-type cells caused a 
loss of pluripotency as assessed by cell morphology 
that was completely rescued in cells expressing the full-
length Wapal immune to the shRNA (FL Wapal Imm, 
Additional file  1: Figure S1b). In addition to rescuing 
the morphology, expression of FL Wapal Imm rescued 
the changes in pluripotency markers such as Nanog and 
Oct4 (Additional file  1: Figure S1c) and suppressed the 
induction of differentiation markers such as Brachyury, 
Bmp2, Cdx2, and Fgf5 (Additional file 1: Figure S1d). We 
assessed protein levels of a subset of markers (Additional 
file  1: Figure S1e), which were decreased (Nanog) or 
increased (Brachyury) after Wapal depletion. Expression 
of FL Wapal Imm blocked the protein changes in Nanog 
and Brachyury observed after Wapal depletion. Collec-
tively, the phenotypic rescue by FL Wapal Imm indicated 
that the loss of pluripotency we observed is secondary to 
Wapal depletion and not an off-target effect of RNAi.
Wapal preferentially occupies genomic regions with other 
cohesin proteins
To identify genomic regions occupied by Wapal, we 
screened for antibodies which met ENCODE criteria [28] 
for chromatin immunoprecipitation coupled with next-
generation sequencing (ChIP-seq). All antibodies tested 
were unsuitable for ChIP-seq; therefore, we turned to a 
metabolic labeling approach to tag Wapal with biotin [24, 
29]. As a first step, we determined the level of expres-
sion of the tagged Wapal constructs stably expressed in 
ESCs. By Western blot (Additional file 2: Figure S2a), the 
total levels of Wapal protein were unchanged between 
two clones expressing tagged Wapal (FB Wapal) ver-
sus a control cell line expressing the biotin ligase BirA 
in the absence of tagged Wapal. As a positive control, 
we included a previously published cell line express-
ing a tagged Nanog (FB Nanog, [29]). Thus, FB Wapal is 
expressed at subendogenous levels, consistent with our 
previous published data, and meets ENCODE criteria for 
ChIP-seq [24, 28, 29]. We performed ChIP-seq on two 
independent FB Wapal clones and subtracted genomic 
regions also present in our BirA-only control for down-
stream analyses (Additional file 2: Figure S2b, see “Meth-
ods” section for details). Five Wapal-binding sites were 
verified by ChIP-qPCR at genomic sites co-occupied by 
Wapal and other subunits of the cohesin complex (Addi-
tional file 2: Figure S2c and below).
As a first step, we analyzed all Wapal-binding sites to 
determine their distribution within the genome. The 
majority (≈60  %) were in extragenic regions, and only 
a small percentage (5  %) were within gene promoters 
(Fig. 2a). Wapal is known to directly interact with the core 
cohesin subunit Rad21 during mitosis to facilitate off-
loading cohesin [5, 30]. We have also demonstrated that 
Wapal interacts with the pluripotency-associated tran-
scription factor Nanog [29]. CTCF, which has pleiotropic 
functions in regulating transcription, directly interacts 
with core cohesin subunits (Smc3, Rad21, and Stag1/2) 
to stabilize DNA loops required for long-range chroma-
tin interactions, although a direct CTCF–Wapal inter-
action has not been reported [3, 31, 32]. We overlapped 
our Wapal-binding sites with those of Rad21, Nanog, 
and CTCF to determine whether they co-occupy the 
same genomic regions (Fig. 2b). We were surprised that 
Wapal and Nanog showed minimal overlap (4  %) with 
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each other, implying that they bind to distinct genomic 
regions. In contrast, Wapal showed a high degree of 
overlap with CTCF (97  %). Genomic sites occupied by 
Wapal showed a strong overlap with core cohesin subu-
nits (75 % overlap between Wapal and Rad21, Fig. 2b, c). 
Collectively, this indicates that Wapal co-occupies DNA 
elements with core cohesin subunits and CTCF. Impor-
tantly, given that CTCF recruits core cohesin subunits to 
DNA elements [3, 33], it is likely that Wapal is recruited 
to these sites in conjunction with other cohesin subunits 
rather than through a direct Wapal–CTCF interaction 
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Fig. 2 a The genomic distribution of Wapal‑binding sites. b Overlap of Wapal‑binding sites with CTCF, Nanog, or core subunits of the cohesin 
complex Smc3 and Rad21. Percentages listed indicate the area(s) of overlap of Wapal‑binding sites with a specific factor. c ChIP‑seq tracks for Adm 
to demonstrate the binding of Wapal, CTCF, and cohesin components. The y‑axis represents the # of ChIP‑seq tags recovered for a given genomic 
bin. The range for each track is displayed to the right of track name. A lower threshold of 2 was set for all tracks to minimize background. In all cases, 
the y‑axis for BirA and Wapal are the same to demonstrate binding specificity
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Wapal does not affect cohesin binding at co‑occupied 
genomic sites
Recently, it has been demonstrated that Wapal antago-
nizes cohesin binding to chromatin during interphase, 
similar to its role during mitosis [5, 12, 13]. However, 
because Wapal’s genomic occupancy was unknown, 
previous studies were performed with bulk analy-
sis of cohesin binding to chromatin and not at specific 
genomic sites [12, 13]. We examined all loci occupied 
by Wapal in combination with core cohesin subunits 
(Rad21, Smc1a, and Smc3) to determine whether Wapal-
occupied genomic sites display lower levels of cohesin 
binding. Genomic sites occupied by Wapal consistently 
displayed higher ChIP-tag densities for Rad21, Smc3, or 
Smc1a (Fig.  3a, b; Additional file  4: Figure S4) as com-
pared to sites where these factors bound without Wapal. 
To confirm this result directly, we measured the chroma-
tin occupancy of Rad21 after Wapal depletion by ChIP-
qPCR at a handful of loci co-occupied by both Wapal and 
Rad21 (Fig. 3c). If Wapal promotes cohesin of off-loading, 
Wapal depletion should increase Rad21 occupancy as 
measured by ChIP-qPCR. We did not observe a statisti-
cally significant increase in Rad21 binding at four loci as 
compared to the empty vector. Collectively, these data 
would indicate that Wapal depletion did not promote off-
loading cohesin at genomic they co-occupy.
Wapal depletion is associated with the derepression 
of Polycomb targets
To assess transcriptome changes after Wapal deple-
tion, we hybridized cDNA generated from ESCs 48  h 
post-lentiviral infection to microarrays. We chose a 
short time frame to minimize differentiation effects and 
enrich for target genes. Wapal-depleted cells showed no 
changes in morphology as compared to empty vector at 
this early time point (Additional file  5: Figure S5a). To 
assess whether pluripotency and differentiation markers 
are altered at this early time point, we performed reverse 
transcription coupled with quantitative PCR (RT-qPCR) 
for various markers that exhibited changes after longer 
periods (6 days) of Wapal depletion. We observed mini-
mal changes in Nanog, Rad21, or Smc3 (Additional file 5: 
Figure S5b). Differentiation markers Brachyury, Bmp2, 
and Cdx2 did not increase. Thus, pluripotency is not 
compromised, and the cells do not differentiate signifi-
cantly 48 h after Wapal depletion.
As further proof that the gene expression changes we 
observed were unique to Wapal depletion and not sec-
ondary to differentiation effects, we downloaded and 
reanalyzed microarray data from ESCs induced to dif-
ferentiate by depleting two pluripotency-associated tran-
scription factors, Nanog or Oct4 [34]. We compared the 
100 genes either upregulated or downregulated by Wapal 
depletion and mapped changes at the same genes after 
Nanog or Oct4 depletion, which are known to induce 
ESCs to differentiate. We observed very little concord-
ance between the gene expression changes seen with 
Wapal and Nanog/Oct4 depletion, implying that at least 
initially the gene expression changes are distinct, even 
though the end result (ESC differentiation) is the same 
(Fig.  4a). We also wondered whether Wapal depletion 
would affect the transcriptome differently than loss of a 
core subunit of the cohesin complex. We depleted Smc3 
using two independent shRNAs and compared the gene 
expression changes with those after Wapal depletion. 
There was a striking similarity in the gene expression pat-
terns when comparing Wapal- and Smc3-depleted cells 
(Fig.  4a), implying that the transcriptome changes were 
very similar. Collectively, our data suggest that Wapal 
depletion induces transcriptome changes similar to Smc3 
loss, but distinct from depletion of Nanog or Oct4. Thus, 
although depletion of Wapal/Smc3 and Nanog/Oct4 all 
causes ESCs to differentiate, they are likely through dis-
tinct mechanisms.
To identify pathways or groups of genes dysregu-
lated by Wapal depletion, we utilized gene set enrich-
ment analysis (GSEA) that measures whether a defined 
set of genes shows a statistically significant, concordant 
difference between two biological conditions [35]. We 
screened 3395 different curated gene sets generated by 
perturbing mammalian cell systems by chemical, RNAi, 
or genetic means to identify Wapal-induced gene expres-
sion changes. We were not surprised that a large num-
ber of gene sets (Additional file 6: Table S5) were either 
upregulated (181) or downregulated (218) after Wapal 
depletion in a statistically significant manner (p value 
<0.01 and false discovery rate-FDR <25 %). As a first step, 
we focused on gene sets derived from pluripotent cells as 
being more pertinent to our analyses. In particular, we 
noted that Polycomb-marked genes were derepressed 
after Wapal depletion in pluripotent cells [36–38]. We 
observed a total of six different Polycomb target gene sets 
derepressed following Wapal depletion (Fig.  4b) with a 
high degree of statistical significance. These data are con-
sistent with existing literature in Drosophila that Wapal 
promotes Polycomb-mediated gene silencing [12]. Two 
gene sets significantly downregulated after Wapal deple-
tion is described as “core” modules of the pluripotent 
state, indicating that genes required to maintain ESCs 
in an undifferentiated state exhibit decreased expression 
(Additional file  5: Figure S5c). Thus, Wapal may play a 
role in silencing of Polycomb target genes in mammalian 
ESCs.
To validate whether Wapal depletion causes a dere-
pression of PcG-silenced genes, we downloaded two dif-
ferent, independent gene sets where PcG target genes 
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were identified [39, 40]. Both of these gene sets demon-
strated a statistically significant upregulation after Wapal 
depletion (Additional file  5: Figure S5d), indicating that 
the gene sets demonstrated increased expression after 
Wapal depletion. As a second, independent confirmation, 
we downloaded and reanalyzed ChIP-seq data for the 
PRC1 mark of ubiquitination of histone 2A (H2AUb1) 
[39] and the PRC2 mark trimethylation of histone 3 on 
lysine 27 (H3K27me3) [41]. Genes marked by either 
PRC1 (H2Aub1) or PRC2 (H3K27me3) in their promoter 
showed a global increase after Wapal depletion, again 
consistent with a role for Wapal in the silencing of PcG 
genes (Additional file  5: Figure S5e). Given that GSEA 
analyzes all genes as a group, we performed a differen-
tial expression analysis to address whether PcG-silenced 
genes are globally derepressed or a subset of genes was 
skewing our analysis. To accomplish this, we generated 
a high-confidence list of PcG-marked genes by the pres-
ence of both H3K27me3 and H2Aub1 in their promoters. 
Next, we assessed transcriptional changes after Wapal 
depletion for each gene (Fig. 4c) and observed a 3:1 ratio 
of genes upregulated versus downregulated after Wapal 
depletion. A similar pattern was seen after Smc3 deple-
tion (Fig.  4c). Collectively, our data indicate that Wapal 
depletion is associated with derepression of PcG-silenced 
genes, similar to the gene expression phenotype observed 
in Drosophila [12].
Wapal depletion selectively reduces Ring1b occupancy 
at PcG‑marked genes
Recent studies in Drosophila [42] indicate that the 
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Fig. 3 a The ChIP‑seq tag densities of Rad21 were compared at genomic sites occupied with (red) or without (green) Wapal in a 2.5 kb window 
around peak center. b ChIP‑seq tag densities for each Rad21 binding site within the genome is visualized as individual rows, with the color scale 
indicating a relative linear gradient from 0 to maximal (100 %) tag values. Two different plots were generated based upon the binding with (left) 
or without (right) Wapal. Row order is from lowest binding to highest binding. c Wapal was depleted with two, independent shRNAs for 48 h and 
genomic occupancy of Rad21 measured by ChIP‑qPCR. The genomic sites (x‑axis) are all co‑occupied by both Wapal and Rad21. All sites dem‑
onstrated statistically significant enrichment in the empty vector sample compared with input (p value <0.05). Plus symbol indicates a statistically 
significant reduction from empty vector (p value <0.05)
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expression by sequestering the PRC1 complex at active 
genes, thereby preventing PRC1 from inducing gene 
silencing. To address whether this is also occurring in 
mammalian cells, we performed ChIP-seq with an anti-
body to Ring1b, a core subunit of the PRC1 complex(es), 
which mediates histone ubiquitination, after Wapal 
depletion. We saw robust binding of Ring1b at PcG-
silenced genes (1455 total), which decreased after Wapal 
depletion (Additional file  7: Figure S6a), consistent 
with Wapal playing a role in PcG targeting. To examine 
whether Wapal depletion induced a broad redistribu-
tion of Ring1b genomic occupancy, we examined a simi-
lar number (1455) of high- and low-expression genes 
from our microarray data. We saw virtually no binding 
of Ring1b to high-expression genes, which was essen-
tially unchanged after Wapal depletion (Additional file 7: 
Figure S6b). We saw low-level binding of Ring1b to low-
expression genes, which again remained unchanged after 
Wapal depletion. Collectively, our data imply that loss of 
Wapal induced the changes in Ring1b occupancy at PcG-
marked genes alone and does not induce redistribution 
across high- and low-expressed genes.
We also hypothesized that if Ring1b genomic changes 
were secondary to differentiation of ESCs, rather than 
genomic occupancy induced by Wapal, we should see 
altered Ring1b occupancy at genes either upregulated or 
downregulated during differentiation. To address this, 
we identified the top 1000 genes upregulated or down-
regulated by depletion of Nanog or Oct4 and assessed 
changes in Ring1b occupancy (Additional file  7: Figure 
S6c). We found that both sets of genes showed minimal 
enrichment for Ring1b and minimal change in Ring1b 
occupancy after Wapal depletion. Given this finding, it 
is highly unlikely that the transcriptome and epigenomic 
changes we observe after Wapal depletion are secondary 
to ESC differentiation.
Wapal is required for maintenance of the PRC2 mark 
H3K27me3 at PcG‑silenced genes
Given that PcG-mediated gene silencing occurs predomi-
nantly through histone modifications deposited within 
promoters, we were surprised that Wapal depletion 
caused PcG-marked gene derepression, given that only 
a small fraction (5  %) of Wapal-binding sites are within 
promoters. In fact, only 3 % of the high-confidence PcG-
marked genes (1455) we identified had a Wapal-binding 
site within 2  kb of the transcriptional start site (TSS, 
Additional file 8: Table S1). In Drosophila, PcG genomic 
targeting is mediated by distal CREs termed Polycomb 
response elements (PREs), but in mammals PREs are 
rare [18, 19, 43]. Additionally in Drosophila, cohesin 
depletion decreases long-range interactions between a 
PRE and target gene(s) [42]. Given this, we hypothesized 
Fig. 4 a The 100 probes most upregulated (red) or downregulated 
(green) with shRNA #1 to Wapal were identified and the Log2 fold 
change (Log2 FC) calculated for Wapal shRNA #2, Smc3 shRNAs, and 
from published studies in which the pluripotency‑associated TFs 
Nanog or Oct4 were depleted by siRNAs. Log2 FC is displayed, with 
the color scheme indicated. b GSEA was used (see “Methods” section 
for details) to identify pathways globally dysregulated by Wapal 
depletion. Six gene sets from pluripotent cells which all exhibited 
substantial enrichment in Wapal‑depleted samples are shown. 
Positive normalized enrichment score (NES) indicates that the gene 
set is enriched in Wapal‑depleted samples as compared to samples 
infected with the empty vector. False discovery rate (FDR < 25 %) and 
p value <0.01 were used to determine statistically significant changes 
in gene set expression. c ChIP‑seq datasets were used to generate a 
list of high‑confidence targets of Polycomb‑mediated gene silencing 
by the presence of both H3K27me3 and H2Aub1 in their promoters 
(1455 genes). For each gene, the expression changes after Wapal or 
Smc3 depletion were measured by microarray. For genes with mul‑
tiple probes, maximal probe deviation was used. Genes that showed 
minimal change in their expression after Wapal depletion or the 
two shRNAs did not demonstrate similar changes were eliminated 
because of possible off‑target effects. Log2 fold change is displayed, 
with a color scheme shown below
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that Wapal may bind at distal CREs but through higher-
ordered chromatin structures be brought into close 
physical proximity of gene promoters. In this case, ChIP-
seq signals can often be detected at a gene’s promoter, 
although the binding is not substantial enough to give a 
positive enrichment through peak-calling algorithms. 
This type of binding, referred to as indirect binding, has 
been extensively studied by one group [44] and identi-
fies long-range chromatin interactions critical for proper 
gene expression. As a first test, we examined the binding 
of Wapal to PcG-marked genes (Fig. 5) and observed that 
Wapal exhibited elevated binding at these gene promot-
ers as compared with the BirA control. We also analyzed 
the subset of PcG-marked genes derepressed after Wapal 
depletion (Additional file  9: Figure S7a, b) and found a 
similar result, indicating that Wapal binding is enriched 
at this subset of promoters as well. A very similar pat-
tern of binding was seen for Smc3 at PcG-marked genes 
(Additional file  9: Figure S7c, d), indicating that Wapal 
and core cohesin components behave similarly in terms 
of binding to PcG-marked genes in ESCs.
To perform a candidate gene analysis, we identified six 
PcG-marked genes derepressed after Wapal depletion 
for further analysis (Additional file  10: Figure S8a). Of 
these six genes, two (Snai2 and Ppp1r3c) had combined 
Wapal-/CTCF-binding sites outside the promoter but 
within 10 kb of the TSS. In both cases (Additional file 10: 
Figure S8b), a clear peak of Wapal binding near the TSS 
could be seen, but did not reach the threshold to be iden-
tified as a binding site during peak calling. Among the 
four other genes (HoxD1, Sox11, Twist1, and Lefty1), we 
were unable to identify a Wapal-binding site within 10 kb 
of the gene, but nonetheless noted evidence of Wapal 
enrichment around the TSS (Additional file  11: Figure 
S9). Collectively, this indicates that Wapal binds predom-
inantly at distal CREs, but nonetheless displays binding at 
PcG-silenced genes.
To determine whether Wapal depletion caused global 
alterations in the activity of either PRC1 or PRC2 com-
plexes, we measured protein levels by Western blotting 
with antibodies specific for PRC marks (H2Aub1 and 
H3K27me3) along with core subunits Ring1B (PRC1), 
Ezh2 (PRC2), and Suz12 (PRC2). In each case, we saw 
trivial changes in the protein expression of the histone 
marks and core PRC subunits (Additional file 12: Figure 
S10). This was surprising given our derepression data and 
implies that global PcG activity is unaffected by loss of 
Wapal. To further study this issue, we performed ChIP-
qPCR at six derepressed genes (HoxD1, Sox11, Twist1, 
Snai2, Ppp1r3c, and Lefty1) 48  h after depleting Wapal 
with two shRNAs (Fig.  6). Primers to the Nanog pro-
moter or two intergenic regions (Ctrl1, 2) were included 
as a negative control; we observed no enrichment at 
these loci using a nonspecific IgG (data not shown). 
Given the results of our GSEA, we focused on the PRC2 
mark H3K27me3. In addition, per the classical models 
of PcG action in mammals PRC1 activity is preceded by 
PRC2-mediated deposition of H3K27me3 [18]. Strikingly, 
we found a substantial loss in the PRC2 mark H3K27me3 
(Fig. 6a). Given these findings, we examined the genomic 
occupancy of Suz12, a core subunit of the PRC2, at these 
same genomic elements (Fig.  6b). We saw a statistically 
significant decrease in Suz12 occupancy at four loci with 
both shRNAs, indicating that the loss of H3K27me3 
is associated with reduced occupancy by PRC2. The 
remaining two loci (HoxD1 and Lefty1) showed a statisti-
cally significant reduction in Suz12 occupancy with only 
one shRNA, but the trend was consistent with the second 
shRNA. Collectively, these data demonstrate that Wapal 
depletion is associated with decreased PRC2 occupancy 
and activity at derepressed genes.
Wapal is required for proper DNA looping of a distal CRE 
in the c‑Fos locus
Given our findings of derepression of genes marked 
by PRC2 after Wapal depletion with binding of Wapal 
to their promoters, we hypothesized that Wapal may 
assist with recruiting distal CREs into gene promoters 
to mediate PRC2 recruitment. There is strong evidence 
that CTCF, which overlaps with 97  % of Wapal-binding 
sites (Fig.  2b), plays a role in Polycomb targeting. First, 
CTCF is required for Polycomb-mediated imprinting of 
the Igf2/H19 locus in murine cells and directly interacts 
with Suz12 [22, 45]. Second, CTCF plays a central role in 





















PcG marked genes (1,455)
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Fig. 5 a A total of 1455 Polycomb‑marked (H3K27me3+/H2Aub1+) 
genes were identified and the ChIP‑seq tag densities measured for 
Wapal and the negative control cell line expressing BirA alone. A 5 kb 
window around the TSS of each gene is shown along the x-axis. b 
Similar to 3B, each row represents an individual Polycomb‑marked 
gene, and the relative binding of Wapal and BirA is shown for each. 
Row order is determined by binding intensity for Wapal. Color gradi-
ent is a relative linear gradient from no binding (0 %) to maximal 
binding (100 %)
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mediating developmental regulation of the Hox clusters, 
which are classically silenced in non-expressed cell types 
through a PcG-dependent mechanism [46–49]. Third, 
our prior work indicates that CTCF-binding sites can 
serve as predictors of Polycomb-mediated gene silencing 
in ESCs [40]. Thus, there is strong evidence in the litera-
ture that CTCF either directly recruits the PRC2 complex 
to silence gene expression or plays an indirect role by 
mediating higher-order chromatin structures.
To address whether Wapal plays a role in facilitating 
chromatin interactions, we focused on the c-Fos locus 
for several reasons. First, it is silenced in pluripotent 
cells and derepressed after Wapal depletion (Additional 
file  13: Figure S11a and [50]). Second, approximately 
14  kb downstream of the gene is a combined Wapal-/
CTCF-binding site, making it the closest genomic site 
capable of regulating c-Fos expression in-cis. Third is 
that the c-Fos locus is relatively isolated, with no other 
protein-coding loci within 100 kb on either side, making 
it less likely this Wapal-/CTCF-binding site is acting on 
other nearby genes.
As a first step, we verified that CTCF mRNA levels were 
unaffected by Wapal depletion (Additional file 13: Figure 
S11a), which was consistent with our microarray data 
(Additional file 14: Table S3). In addition, we verified that 
Wapal depletion resulted in decreased H3K27me3 at the 
c-Fos promoter (Additional file 13: Figure S11b). We also 
detected the presence of H3K27me3 at the Wapal-bind-
ing site, indicating that PRC2 activity is also present at 
this site distal to the c-Fos promoter. Surprisingly, Wapal 
depletion had minimal effect on H3K27me3 levels at this 
site, indicating that Wapal depletion did not cause global 
changes in H3K27me3 levels across the entire locus. Col-
lectively, these data indicate that Wapal is required for 
Polycomb-mediated silencing of c-Fos expression.
To address whether Wapal plays a role in regulating 
the interaction between this distal CRE and the c-Fos 
promoter, we utilized chromosomal conformational cap-
ture (3C) to directly measure the interaction frequency 
between the two. An area spanning 26  kb downstream 
of the c-Fos promoter was probed for interactions using 
an anchor primer near the TSS. An interaction was 
observed between the c-Fos promoter and the Wapal/
CTCF distal CRE in cells infected with the empty vector, 
but no interactions were observed with primers flank-
ing the Wapal-binding site (Fig.  7). Wapal depletion by 
two shRNAs results in decreased interaction between 
the 14.3 kb distal CRE and c-Fos promoter. Importantly, 
this result was observed 2  days following Wapal deple-

















































































Fig. 6 a ChIP‑qPCR was performed at six genomic loci (HoxD1, Sox11, Twist1, Snai2, Ppp1r3c, and Lefty1) all derepressed after Wapal depletion with 
an antibody specific to H3K27me3. Nanog, which is well expressed in ESCs, is used as a negative control. Two additional negative controls (Ctrl 1 
and Ctrl 2) are included—genomic regions within gene deserts. Genomic coordinates amplified by each primer set are given in Additional file 15: 
Table S4. Asterisk indicates a statistically significant difference from input (p value <0.05). b to a, but with an antibody to a core subunit of the PRC2 
complex, Suz12. Asterisk indicates a statistically significant difference from input. Plus symbol indicates a statistically significant reduction in Suz12 
enrichment from the empty vector control
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indicates that Wapal is necessary for the distal CRE to 
interact with the c-Fos promoter. Collectively, these data 
imply that Wapal directly binds to a distal CRE within the 
c-Fos locus and assists with its recruitment to the TSS 
to mediate transcriptional repression through the PRC2 
complex. Whether this is through participating in the 
chromatin looping directly or indirectly by influencing 
core cohesin subunits remains an open question.
Discussion
Our work demonstrates that Wapal is critical to ESC 
pluripotency. This is consistent with a recent report that 
Wapal−/− mice die early in embryogenesis [13]. Given 
our cell-cycle data (Fig.  1e), it appears that mitosis is 
unaffected 48 h after Wapal depletion and therefore likely 
not responsible for the loss of pluripotency we observe. 
The lack of cell-cycle changes in our experiments may 
result from redundancy by the separase complex, which 
can mediate sister chromatid separation independent 
of Wapal [4, 51]. A recent report using heterokaryons 
indicates that Rad21 deletion may induce pluripotency 
factor expression and can improve reprogramming effi-
ciency through increased expression of c-Myc [11]. Given 
the redundancy of the separase complex and the fact we 
use a depletion rather than genetic deletion strategy, our 
findings are most consistent with Wapal playing a critical 
role in pluripotency through modulating gene expression 
rather than altering the cell cycle. However, given these 
contradictory findings, further studies to understand 
Wapal and cohesin’s role in regulating pluripotency are 
required to separate effects on the cell cycle versus gene 
expression.
The biology of the cohesin complex has extensively 
been studied in mitosis, and the role of different subunits 
for sister chromatid cohesin has been used as a frame-
work to understand their role during transcriptional 
regulation. Therefore, the canonical function of Wapal 
(off-loading cohesin) has been used as a model to under-
stand Wapal’s role during interphase. Genetic deletion 
of Wapal [13] or a dominant-negative Wapal allele [12] 
increased bulk cohesin interactions with chromatin, as 
measured by fluorescence recovery after photobleaching 
(FRAP). The studies described herein used an alterna-
tive approach and identified >8000 genomic sites occu-
pied by Wapal in ESCs by ChIP-seq. By overlaying these 
data with datasets for other core cohesin subunits, we 
demonstrate that Wapal co-occupies genomic sites with 
other cohesin proteins. In fact, genomic sites occupied by 
cohesin subunits with Wapal demonstrate slightly higher 
cohesin ChIP-tag density than sites occupied without 
Wapal, and there was minimal change in Rad21 chroma-
tin occupancy after Wapal depletion (Fig.  3). This illus-
trates that Wapal does not appear to antagonize cohesin 
binding at these sites. Our data cannot exclude that 
Wapal affects the kinetics of cohesin occupancy at shared 
sites, given that we measure steady-state levels in a popu-
lation of cells by ChIP-qPCR, rather than dynamic asso-
ciation rates which are measured by FRAP. However, we 
favor a model in which Wapal binds to specific genomic 
site in conjunction with other cohesin complex members. 
We favor this model because Wapal depletion phenocop-
ies the biology of core cohesin subunits such as Rad21 or 
Smc3 in terms of (1) effects on ESC pluripotency after 
depletion; (2) chromatin occupancy; (3) transcriptome 
changes; (4) facilitating chromatin loops. At other sites 
within the genome not specifically occupied by Wapal, it 
likely off-loads cohesin to prevent chromatin condensa-
tion [13]. This highlights that Wapal’s role in regulating 
gene expression appears similar to core cohesin subunits 
in our studies.
Our data demonstrate that Wapal plays a critical role 
in regulating the epigenome, specifically PRC2-mediated 







































Distance from c-Fos TSS (kb) 
Empty Vector 
Wapal shRNA #1 




Fig. 7 Top panel shows ChIP‑seq tracks for PRC1 (H2Aub1, Ring1b), 
PRC2 (H3K27me3, Suz12, Ezh2), Wapal, CTCF, and BirA only as a 
negative control. Scale for each track is listed. Primers for 3C are 
shown below the gene, with the anchor primer labeled. Bottom panel 
normalized interaction frequency for different primers from cells 
infected with the empty vector or two different shRNAs to Wapal. 
Asterisk indicates a statistically significant (p value <0.05) reduction 
from empty vector
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Wapal-depleted cells to lose pluripotency remains an 
unresolved issue. Deletion of either the catalytic subu-
nit (Ezh2) or the core subunit (EED) required for PRC2 
stability causes an early embryonic lethal phenotype 
in mice. However, both Ezh2−/− and EED−/− ESCs are 
pluripotent even though they lack PRC2 activity [52, 53]. 
In contrast, total H3K27me3 levels are unchanged after 
Wapal depletion by RNAi, implying that global PRC2 
activity is preserved, a clear distinction with EED−/− 
cells that lack H3K27me3. It is more likely that improper 
genomic localization of PRC2, rather than a complete loss 
of its activity, results in a loss of pluripotency. Polycomb-
silenced genes are typically developmental regulators 
[54, 55], and therefore, derepression of even a handful of 
these loci would be sufficient to mediate a loss of pluripo-
tency. For example, AP-1 family members such as c-Fos 
and c-Jun appear to be negative regulators of pluripo-
tency, and depletion of either can enhance defined factor 
reprogramming [50].
Most intriguing is the role of Wapal in repression of 
c-Fos expression, with Wapal depletion associated with 
decreased H3K27me3 at the promoter and reduced inter-
action with a CTCF-occupied distal CRE. Given the high 
degree of overlap between Wapal and CTCF (97 %), we 
hypothesize two different models to explain how Wapal 
and CTCF may facilitate Polycomb targeting to effect 
gene silencing (Fig. 8). In the first (Fig. 8a), CTCF targets 
the PRC2 complex through a direct physical interaction 
with Suz12, similar to what occurs at Igf2/H19 [22]. In 
this model, Wapal and cohesin work together to stabi-
lize the resulting DNA loop, permitting gene silencing. 
In the second (Fig. 8b), CTCF blocks a distal transcrip-
tional enhancer from accessing the gene promoter. In this 
model, Polycomb complexes bind to all sites of transcrip-
tion and non-specifically silence them [21, 56]. Tran-
scriptional enhancers are then required for Polycomb 
eviction, thereby facilitating gene expression [57]. The 
role of CTCF in enhancer blocking is well established and 
dependent on cohesin function [3]. While our data can-
not distinguish between the two models, further studies 
utilizing genomic editing to delete different CREs cou-
pled with genome-wide chromatin capture technologies 
(such as 4C, [58]) can be used to address this fundamen-
tal question.
Seminal studies in Drosophila regarding the role of 
cohesin in regulating gene expression and the epigenome 
demonstrate some similar but also disparate results from 
our own. In Drosophila, cohesin depletion decreased 
long-range interactions between a PRE and the inv-en 
gene complex [42], which is analogous to our results 
(Fig. 7). In contrast, work from Dr. Dale Dorsett’s labora-
tory [42, 59, 60] using the Drosophila wing imaginal disk 
as a model indicates that cohesin plays a fundamental 
role in sequestering the PRC1 complex at actively tran-
scribed genes, thereby limiting its availability to bind to 
silenced genes. This sequestration is facilitated by a pro-
tein/protein interaction between cohesin and PRC1 in 
Drosophila [61]. While this exciting model may explain 
some of our observation, key distinctions between Dros-
ophila and mammals likely prevent a direct compari-
son of cohesin’s function in regulating gene expression 
between these species. Specifically, cohesin genomic 
occupancy in Drosophila and mammals differs signifi-
cantly [62]. In mammals, Wapal and cohesin predomi-
nantly bind chromatin in conjunction with CTCF [3, 63], 
mediated by a protein/protein interaction between CTCF 
and Stag2 [33]. In contrast, there are multiple insulator 
proteins in Drosophila beyond dCTCF (BEAF-32, Zw5, 
and Su(Hw)), which lack mammalian homologues and 
currently a paucity of evidence that these proteins inter-
act with cohesin [64]. In fact, the Drosophila protein 
CP190 plays a critical role in mediating chromatin loop-
ing but lacks a mammalian homologue [44, 65]. Thus, it is 
likely that fundamental differences in the genomic locali-
zation of cohesin between Drosophila and mammals dur-
ing interphase make direct comparisons between these 
species challenging.
Conclusions
The core cohesin subunits play a critical role in transcrip-
tional regulation by facilitating DNA loops that permit 
the interaction of distal cis-regulatory regions with gene 


















Fig. 8 Two models to explain the role of Wapal and cohesin in regu‑
lating PRC2 targeting. a A CTCF‑occupied distal CRE is responsible 
for recruiting PRC2 to mediate gene silencing. The recruitment is 
through a direct CTCF:Suz12 interaction [22]. In this model, the CTCF 
site would function as a mammalian PRE. b Polycomb complexes tar‑
get all sites of transcription, and need to be “evicted” from the TSS by 
a transcriptional enhancer. CTCF prevents this by “blocking” enhancer 
access to gene. Cohesin facilitates the required DNA loop to stabilize 
the CTCF/gene chromatin interaction
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protein Wapal in regulating gene expression has not 
been described. We show that Wapal depletion by RNAi 
induces the differentiation of ESCs, implying that it is 
required for pluripotency much like other core cohesin 
subunits. Wapal co-occupies genomic sites distal to genes 
in conjunction with other core cohesin subunits and 
CTCF, and at genomic sites it occupies Wapal does not 
appear to promote cohesin of off-loading. Wapal deple-
tion causes a global derepression of Polycomb-silenced 
genes, although overall PcG activity remains unchanged. 
Lastly, Wapal facilitates the interaction between a distal 
CRE with the c-Fos promoter. Collectively, these data 




Gelatin-adapted ESCs (129SVJ-dervied) were cultured 
as previously [25]. Bright-field images and alkaline phos-
phatase staining were performed as previously [24].
Protein, RNA isolation, and quantitative PCR
Total RNA and total protein were collected as previ-
ously [25, 66]. If needed, RNA was further purified fol-
lowing manufacturer’s protocol (RNeasy Micro, Qiagen). 
cDNA conversions were performed using the iScript 
cDNA Synthesis kit (Biorad) according to manufacturer’s 
protocols. Quantitative real-time PCR (qPCR) was per-
formed as previously [24, 25]. Primers used for reverse 
transcriptase-qPCR (RT-qPCR), ChIP-qPCR, and 3C are 
listed in Additional file 15: Table S4. The genomic regions 
of the primers (3C) or the amplified region (ChIP-qPCR) 
are indicated in Additional file 15: Table S4 (mm9).
Western blots
Whole-cell extracts were prepared from cells by lysis in 
50  mM Tris (pH 8.0), 10  % glycerol, 0.7  % NP-40 sub-
stitute (Sigma, 74385), 0.1  mM EDTA, 250  mM NaCl, 
50  mM NaF, and 0.1  mM Na3VO4. Protease inhibitors 
were added to buffer as follows: 1:1000 DTT (Sigma, 
646563), 5:1000 PMSF (Sigma, 93482-50ML-F), and 
1:1000 Protease Inhibitor Cocktail (Sigma, P8340-5ML). 
Equal protein (10–50  μg) was run using standard SDS-
PAGE separation techniques and blotted. Protein quan-
tification was performed with Image J. All samples were 
normalized to a loading control (either GAPDH or total 
histone H3) and an empty vector or normal control.
Antibodies
Smc3 (Abcam, Ab9263), Sall4 (Abcam, Ab29112), 
Wapal (Abcam, Ab70741), Scc1/Rad21 (Abcam, Ab992), 
Nanog (Millipore, AB5731), GAPDH-HRP (Santa Cruz, 
sc-25778), total H3 (Active Motif, 61278), H3K27me3 
(Millipore, 07-449), H3K4me3 (Active Motif, 39916), 
anti-Brachyury (Santa Cruz, sc-17743), anti-v5 (Invitro-
gen, 46-0708), Streptavidin–HRP (Invitrogen, SA1007), 
anti-Suz12 (Santa Cruz, sc-46264), anti-Ezh2 (Millipore, 
17-662), anti-Ring1b (Western Blot-Active Motif, 39664; 
ChIP-seq Abcam, Ab101273), anti-H2Aub1 (Cell Signal-
ing, 8240).
Lentiviral generation and RNAi experiments
RNAi/TRC consortium lentiviral constructs were 
obtained from either Open Biosystems or Sigma-
Aldrich. The following constructs were utilized: 
pLKO.1 is the parental viral vector without shRNA. 
Sall4 (TRCN0000097821) was used as a positive con-
trol and can be rescued by the Sall4b cDNA [24], indi-
cating that the loss of pluripotency is not secondary to 
off-target effects. Other lentiviruses used are against 
Wapal (TRCN0000178287, TRCN0000177268) or Smc3 
(TRCN0000109007, TRCN0000160440). Lentiviruses 
were generated and ESCs infected as done previously 
[25]. Puromycin selection (4  μg/mL) was started after 
infection and continued daily for 2–6  days to select for 
cells with a high multiplicity of infection.
Chromatin immunoprecipitation
Antibody-mediated ChIP and biotin-mediated ChIP 
(bioChIP) were performed similar to our previous work 
[25]. Primers used for ChIP-qPCR are indicated in Addi-
tional file 15: Table S4. Antibodies used are as above. A 
modified version of [67] was used for antibody-mediated 
ChIP on histones. Briefly, cells were cross-linked for 
5 min at room temperature with 1 % fresh formaldehyde. 
Reaction was quenched with glycine (125 mM final con-
centration) for 5  min at room temperature. Cells were 
lysed in 1  % SDS lysis buffer (1  % SDS, 10  mM EDTA, 
50 mM Tris–HCl pH 8.0, protease inhibitors). Chromatin 
was sonicated to a mean size of 300–500 bp. Lysed cells 
were cleared by centrifugation and supernatant diluted 
1:20 with ChIP dilution buffer (0.01  % SDS, 1.1  % Tri-
ton X-100, 1.2  mM EDTA, 16.7  mM Tris–HCl, pH8.0, 
167  mM NaCl, protease inhibitors). In total, 2–4  μg of 
antibodies were added and incubated overnight with 
constant rotation at 4 °C. Washed Dynal Protein A beads 
(Invitrogen) were added and incubated at 4  °C for an 
additional 90 min. Beads were isolated with a magnet and 
then washed with ChIP dilution buffer, low-salt buffer 
(0.1  % SDS, 1  % Triton X-100, 2  mM EDTA, 20  mM 
Tris–HCl pH 8.0, NaCl 150  mM), LiCl wash (250  mM 
LiCl, 0.5  % NP-40, 0.5  % deoxycholate, 1  mM EDTA, 
10 mM Tris–HCl pH 8.0), and TE. DNA was eluted and 
de-cross-linked overnight at 65 °C in SDS elution buffer 
(1 % SDS, 10 mM EDTA, 50 mM Tris–HCl pH 8.0). The 
next day RNase A and proteinase K were added, and the 
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DNA was precipitated in the presence of glycogen. DNA 
for downstream applications was quantitated by fluorom-
etry (Qubit, Invitrogen), and equal DNA was used for 
each ChIP-qPCR and normalized to sheared, non-IP’d 
genomic DNA (input).
Plasmid and cell line generation
The Wapal open reading frame was obtained from Open 
Biosystems and used as a template to perform site-
directed mutagenesis to disrupt the third base pair of 
each codon within the shRNA complementary region, 
thus making it immune to the shRNA without altering 
the protein-coding sequence. A c-terminal v5 epitope tag 
was added to aid in detection. The cDNA was then cloned 
into the pPyCAG iH vector ([68], hygromycin resistance) 
for expression under a ubiquitous (CAG) promoter. CJ9 
ESCs were electroporated with the linearized plasmid in 
the presence of hygromycin and individual clones iso-
lated, as we have done previously [24]. All constructs 
were fully sequenced to ensure the coding sequence was 
correct. Expression of a tagged protein of the appropri-
ate size was confirmed for each clone. The Wapal cDNA 
was cloned into the Flag/Bio expression vector and elec-
troporated into BirA-expressing ESCs as we have done 
previously [24]. Individual colonies were expanded, and 
expression of a tagged, biotin-containing band of the cor-
rect size was verified by Western Blot with streptavidin 
and IP with streptavidin and blotting with anti-Wapal.
Generation of Oct4:IRES:EGFP reporter ESC line
To generate the Oct4:IRES:EGFP reporter line used in 
Additional file  1: Figure S1A, a published guide RNA 
(gRNA) and plasmid were used to target CJ9 ESCs 
[27] and insert an IRES:EGFP cassette into the 3′ UTR 
of Oct4. Briefly, a guide RNA specific to the 3′ UTR of 
the Oct4 locus (CTCAGTGATGCTGTTGATC) was 
cloned into the Cas9-expressing vector px459 [69]. A 
homology donor repair (HDR) vector containing an 
IRES:EGFP cassette flanked by homology regions from 
Oct4 was obtained from Addgene (plasmid #48681) and 
co-transfected along with the guide RNA into 1–2 × 106 
wild-type ESCs. Transfected cells were selected with 
puromycin (2 μg/mL first 2 days only) and G418 (500 μg/
mL daily) until single colonies appeared. Individual 
clones were isolated and cells that expressed GFP only in 
the pluripotent state were isolated, expanded, and used 
for subsequent experiments.
ChIP‑seq
Biotin-mediated Chromatin IP (bioChIP) was performed 
similar to previously [24, 25]. Briefly, 10–20  ng of ChIP 
DNA from two independently derived Flag/Bio Wapal 
clones, and control cells (expressing BirA) alone, along 
with an equal amount of sheared genomic DNA (input), 
were used for library generation (NEXTflex Chip-seq kit, 
Bioo Scientific) according to manufacturer’s protocol. 
Samples were sequenced on an Illumina HiSeq 2000 at 
Beijing Genomics Institute and obtained at least 50 mil-
lion aligned reads per sample. For ChIP-seq on Wapal-
depleted cells, a similar approach was used but cells were 
cross-linked and chromatin prepared 48 h post-infection. 
Library preparation was performed with NEB E7645 and 
sequenced on an Illumina NextSeq 500, 75 cycles, sin-
gle end. The first 5  bp was trimmed from all reads due 
to lower Q30 scores, and then, the next 49 bp was used 
for alignment to recreate the analysis pipeline used for 
Wapal. After adaptor removal, reads were aligned to a 
reference genome (mm9) using Bowtie [70] with the fol-
lowing parameters (-e 70 -n 2 -k 1 -m 1), and then, peak 
calling was performed with MACS [71] using the default 
parameters (p value of 10−5). For each sample (input, BirA 
ChIP, Wapal ChIP #1 and #2), at least 50 million aligned 
reads were used for peak calling, and peak calling was per-
formed by comparing experimental samples to input as a 
control (i.e., two-sided peak calling). Annotation of peaks 
was done using CisGenome [72]. Published datasets were 
obtained from the GEO Omnibus and are listed in Addi-
tional file  16: Table S2 for the following ChIP-seq data-
sets (Smc1a, Smc3, Rad21, CTCF, H3K27me3, Nanog, 
Stag1, Stag2, H2Aub1, Ring1b, Ezh2, and Suz12). All 
downloaded SRA-type files were analyzed using the same 
parameters as above. A file in.bed format with all Wapal 
peaks regions is included in Additional file 8: Table S1. A 
total of 266 genomic sites displayed significant biotinyla-
tion in the BirA-only-expressing cells, likely secondary 
to biotinylated histones, and are also included in Addi-
tional file 8: Table S1. We subtracted these regions from 
our subsequent analysis and identified a total of 8296 
Wapal-binding sites between the two datasets. ChIP-seq 
tag pileup files were normalized using Haystack [73] when 
comparisons were made between different wiggle files.
Transcriptome analysis
Total RNA was extracted using Trizol from ESCs infected 
with either empty vector (pLKO.1) or two, independent 
shRNAs to Wapal or Smc3. Two biological replicates for 
each shRNA or empty vector were used. Probes were 
generated and hybridized to Affymetrix Mouse Genome 
430 2.0 arrays as previously [24]. CEL files were normal-
ized using RMA [74] and subsequently processed using 
GenePattern [75] and GSEA [35] similar to our previous 
work using default parameters [24] unless otherwise indi-
cated. For our initial GSEA, we used the C2:CGP group 
of datasets (v5) available through the Molecular Signa-
ture Database (MSigDB; http://www.broadinstitute.org/
gsea/msigdb/collections.jsp).
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Cell‑cycle analysis
ESCs were trypsinized, counted, and washed with PBS-/-. 
In 100 μL of PBS-/-, 0.5–1 × 106 cells were resuspended, 
and 1.9  mL of cold 70  % ethanol was added in a drop-
wise fashion to fix cells. Cells were incubated at −20  °C 
for 30 min, spun down, and RNase digested at 37  °C for 
30 min. Cells were stained with propidium iodide (PI, final 
concentration 10 μg/mL) for at least 5 min. Flow cytom-
etry was performed and data was analyzed with FlowJo.
Chromosome conformation capture (3C): modified 
from [76]
Library preparation
For each library generated, approximately 15  ×  106 
mESC were fixed in a 1 % formaldehyde/10 % FBS solu-
tion for 10  min. Nuclei were isolated and digested with 
1000U HaeIII (NEB R0108M) overnight at 37  °C while 
shaking. DNA was ligated with 7000 units of T4 DNA 
ligase (NEB M0202M) for 5 h at 16 °C. Samples were then 
de-cross-linked overnight at 65  °C. Following two phe-
nol/chloroform extractions, the library was precipitated 
with a standard ethanol/sodium acetate protocol.
BAC preparation
Twenty micrograms of BAC RP23206I6 (CHORI) was 
digested with 1250U HaeIII overnight at 37  °C while 
shaking. Digested BAC DNA was phenol/chloroform 
extracted then ethanol precipitated. BAC was then 
ligated with 7000 units of T4 DNA ligase overnight in 
a 16  °C water bath. Ligated BAC template was phenol/
chloroform extracted and ethanol precipitated. Template 
was resuspended in TE.
Determination of interaction frequency
Template and BAC loading were normalized by subtract-
ing the CT of the internal primers from the CT of the test 
primers yielding ∆CT. The ∆CT from the BAC was then 
subtracted from ∆CT of the template to remove random 
interactions and PCR biases from the test primers. Inter-
action frequency is then determined by the value of 2^−
(∆CT of template - ∆CT of BAC).
Statistical analysis
Unless otherwise stated, t test comparisons were made 
and p values <0.05 were considered significantly differ-
ent. All error bars are SEM derived from three experi-
ments unless specifically stated otherwise.
Genome‑wide datasets
All microarray and ChIP-seq data are available in GEO 
Omnibus (GSE63325).
Additional files
Additional file 1: Figure S1. A) Cells expressing EGFP under the control 
of the Oct4 locus were generated (see Materials and Methods section 
for details). GFP mean fluorescence intensity (MFI) was measured 2, 4, 
and 6 days post‑infection. All data are normalized to the GFP MFI of cells 
infected with the empty vector on day 0, displayed on the y‑axis. B) 
Wild‑type (WT) or cells expressing a full‑length Wapal cDNA immune 
to shRNA #2 were infected and bright field (10x, top panel) or alkaline 
phosphatase stained (4x, bottom panel) are shown 6 days post‑infection. 
Domain structure of Wapal is shown to right of images. C) mRNA levels of 
different cohesin (Wapal and Smc3) and pluripotency (Nanog, Oct4) are 
shown. A linear scale of relative expression (compared to WT cells infected 
with the empty vector) is shown on the y‑axis. * indicates a statistically 
significant reduction from the WT+empty vector control (p value<0.05). 
D) mRNA levels of differentiation markers. A Log10 scale (left) or linear 
(right) of relative expression (compared to WT cells infected with the 
empty vector) is shown on the y‑axis. * indicates a statistically significant 
increase from the WT+empty vector control (p value<0.05). + indicates a 
statistically significant reduction in expression from WT+Wapal shRNA #2 
(p‑value<0.05). E) Western blots on cells six days after infection. Antibod‑
ies used are indicated on the right. E=empty vector, W= Wapal shRNA #2, 
WT= wild‑type.
Additional file 2: Figure S2.  A)Western blot of either the parental 
(BirA) or cells expressing Flag/biotinylated (FB) version of Nanog or Wapal. 
Streptavidin HRP specifically recognizes the biotinylated versions of the 
proteins. * indicates nonspecific bands. B) Overlap between the ChIP‑seq 
datasets derived from BirA cells and the two experimental cell lines. C) 
Five different Wapal sites identified by ChIP‑seq were confirmed by ChIP‑
qPCR. All FB Wapal samples yielded statistically significant (p value <0.05) 
enrichment compared to input.
Additional file 3: Figure S3. IGV screen captures of the c-Myc locus 
occupied by multiple members of the cohesin complex, including Wapal. 
Other loci tested in Figure S2c are shown in other figures (see below). For 
each graph, the genomic coordinates are shown below the x‑axis. The 
y‑axis represents the # of ChIP‑seq tags recovered for a given genomic 
bin. The range for each track is displayed to the right of track name. A 
lower threshold of 2 was set for all tracks to minimize background. In all 
cases, the y‑axis for BirA and Wapal is the same to demonstrate binding 
specificity.
Additional file 4: Figure S4. The ChIP‑seq tag densities of Smc3 or 
Smc1a were compared at genomic sites occupied with (Red) or without 
(Green) Wapal in a 2.5kb window around peak center. ChIP‑seq tag densi‑
ties for each Smc3 or Smc1a binding site within the genome are visualized 
as individual rows, with the color scale indicating a linear gradient from 
0 to maximal tag values. Two different plots were generated based upon 
the binding with (left) or without (right) Wapal. Row order is from lowest 
binding to highest binding. # of sites used for each plot is indicated below.
Additional file 5: Figure S5. A) Bright‑field images of ESCs 48 hours 
post‑infection with the empty vector or two shRNAs to Wapal. B) RT‑
qPCR to measure transcript levels 48hrs after Wapal depletion with two 
shRNAs. * indicates a statistically significant difference from empty vector 
(p value<0.05). C) Two gene sets recovered from gene set enrichment 
analysis that showed negative enrichment in the Wapal‑depleted cells. 
NES=normalized enrichment scores, negative score indicates enrich‑
ment in the empty vector sample. D) Two independently derived lists of 
Polycomb target genes were used as gene sets and displayed significant 
enrichment with positive NES scores in Wapal‑depleted samples, indicat‑
ing that these genes are derepressed after Wapal depletion. E) Similar to 
(D), but using genes identified as PRC1 marked (H2Aub1) or PRC2 marked 
(H3K27me3) in their promoter.
Additional file 6: Table S5. All statistically significant altered gene sets 
from GSEA analysis after Wapal depletion.
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2A; H3K27me3: trimethylation of histone 3 on lysine 27; TSS: transcriptional 
start site; 3C: chromosomal conformational capture; AP: alkaline phosphatase; 
MOI: multiplicity of infection; NES: normalized enrichment scores; FDR: false 
discovery rate; WT: wild‑type.
Authors’ contributions
CS and MR performed the bulk of the experiments. JP, S. Roumiantsev, 
SM, and SB performed specific experiments. KP performed the bulk of the 
computational analyses presented. SJ, MJH, LP, and SR performed the addi‑
tional analyses. GCY provided critical assistance with the development and 
design of many of the experiments and computational analyses. S. Rao con‑
ceived the study and participated in the design and analysis and performed 
all the transcriptome analyses shown, as well as writing the manuscript. All 
authors read and approved the final manuscript.
Author details
1 Blood Research Institute, BloodCenter of Wisconsin, 8727 West Watertown 
Plank Road, Milwaukee, WI 53226, USA. 2 Department of Cell Biology, Neu‑
robiology, and Anatomy, Medical College of Wisconsin, Milwaukee, WI, USA. 
3 Dana Farber Cancer Institute, Harvard School of Public Health, Boston, MA, 
USA. 4 Department of Pediatrics, Medical College of Wisconsin, Milwaukee, 
WI, USA. 5 Department of Pediatrics, Massachusetts General Hospital, Boston, 
MA, USA. 6 Sanford Research Center, Sanford School of Medicine, University 
of South Dakota, Sioux Falls, SD, USA. 
Acknowledgements
This work was supported in part by funding from NHBLI (HL087951), a pilot 
grant from the American Cancer Society (Institutional Research Grant #86‑
004), the Children’s Research Institute, the Midwest Athletes against Childhood 
Cancer, and Hyundai Hope on Wheels, and generous philanthropic support 
from Mr. Douglas Ziegler, all to S. Rao.
Competing interests
The authors declare that they have no competing interests.
Received: 10 September 2015   Accepted: 23 March 2016
References
 1. Dorsett D. Cohesin: genomic insights into controlling gene transcription 
and development. Curr Opin Genet Dev. 2011;21:199–206.
 2. Kagey MH, Newman JJ, Bilodeau S, Zhan Y, Orlando DA, van Berkum NL, 
Ebmeier CC, Goossens J, Rahl PB, Levine SS, Taatjes DJ, Dekker J, Young 
RA. Mediator and cohesin connect gene expression and chromatin 
architecture. Nature. 2010;467:430–5.
 3. Wendt KS, Yoshida K, Itoh T, Bando M, Koch B, Schirghuber E, Tsutsumi S, 
Nagae G, Ishihara K, Mishiro T, Yahata K, Imamoto F, Aburatani H, Nakao M, 
Imamoto N, Maeshima K, Shirahige K, Peters J‑M. Cohesin mediates tran‑
scriptional insulation by CCCTC‑binding factor. Nature. 2008;451:796–801.
 4. Nasmyth K, Haering CH. Cohesin: its roles and mechanisms. Annu Rev 
Genet. 2009;43:525–58.
 5. Kueng S, Hegemann B, Peters B, Lipp J, Schleiffer A, Mechtler K, Peters J. 
Wapl controls the dynamic association of cohesin with chromatin. Cell. 
2006;127:955–67.
 6. Shintomi K, Hirano T. Releasing cohesin from chromosome arms in 
early mitosis: opposing actions of Wapl–Pds5 and Sgo1. Genes Dev. 
2009;23:2224–36.
 7. Seitan VC, Hao B, Tachibana‑Konwalski K, Lavagnolli T, Mira‑Bontenbal H, 
Brown KE, Teng G, Carroll T, Terry A, Horan K, Marks H, Adams DJ, Schatz 
DG, Aragon L, Fisher AG, Krangel MS, Nasmyth K, Merkenschlager M. A 
role for cohesin in T‑cell‑receptor rearrangement and thymocyte differen‑
tiation. Nature. 2011;476:467–71.
 8. Nitzsche A, Paszkowski‑Rogacz M, Matarese F, Janssen‑Megens EM, 
Hubner NC, Schulz H, De Vries I, Ding L, Huebner N, Mann M, Stunnen‑
berg HG, Buchholz F. RAD21 cooperates with pluripotency transcription 
factors in the maintenance of embryonic stem cell identity. PLoS One. 
2011;6:e19470.
 9. Dowen JM, Fan ZP, Hnisz D, Ren G, Abraham BJ, Zhang LN, Weintraub 
AS, Schuijers J, Lee TI, Zhao K, Young RA. Control of cell identity genes 
occurs in insulated neighborhoods in mammalian chromosomes. Cell. 
2014;159:374–87.
 10. Dowen JM, Bilodeau S, Orlando DA, Hübner MR, Abraham BJ, Spector DL, 
Young RA. Multiple structural maintenance of chromosome complexes at 
transcriptional regulatory elements. Stem Cell Rep. 2013;1:371–8.
 11. Lavagnolli T, Gupta P, Hörmanseder E, Mira‑Bontenbal H, Dharmalingam 
G, Carroll T, Gurdon JB, Fisher AG, Merkenschlager M. Initiation and 
Additional file 7: Figure S6. A) The normalized ChIP‑seq tag densities 
of Ring1b were compared at PcG‑marked genes in cells infected with 
the empty vector (Black) or two separate shRNAs to Wapal (Red). X‑axis 
is the distance in bp around TSS, and y‑axis is the normalized tag #. Heat 
maps are similar to S4. A total of 1,455 PcG‑marked genes were used for 
these analyses. B) Ring1b binding before (Black) or after Wapal depletion 
(Red) was measured at 1455 genes (same # as in A), which were either 
expressed at low (left) or high (right) levels. C) Similar to B, but genes 
where went down (left) or up (right) after depletion of Nanog or Oct4 in 
ESCs are shown.
Additional file 8: Table S1. Genomic sites occupied by Wapal.
Additional file 9: Figure S7. Both (A) and (B) are similar to Figure 5, 
but only a subset of genes is used. A) 384 Polycomb‑marked genes 
derepressed after Wapal depletion were used to measure the number of 
ChIP‑seq tags recovered for either Wapal or the negative control BirA. B) 
For 384 genes, the relative binding at each gene is shown for Wapal and 
BirA alone samples. C) Smc3 binding at 1,455 PcG‑marked genes. Smc3 
control is an input sample. D) A total of 1,455 PcG‑marked genes were 
used to measure number of ChIP‑seq tags recovered for Smc3.
Additional file 10: Figure S8. A) Log2 fold change in expression of six 
Polycomb‑marked genes derepressed after Wapal depletion with two 
different shRNAs. Color scheme shown to right. B) IGV screen captures of 
two loci (Snai2 and Ppp1r3c) in which a combined Wapal‑/CTCF‑binding 
site is >2kb from the TSS, but also illustrates increased binding of Wapal 
around the TSS. Other aspects are similar to Figure S3.
Additional file 11: Figure S9. Similar to (S8b), but for additional loci. 
A clear peak of Wapal binding is not present within 10kb of these four 
derepressed genes.
Additional file 12: Figure S10. Protein levels after Wapal depletion of 
various histone marks and core components of the PRC1 and PRC2 com‑
plexes. Total H3 is used as a loading control. Quantification is described 
within Materials and Methods.
Additional file 13: Figure S11. A) mRNA expression of Smc3, CTCF, and 
c‑Fos 48 hours after Wapal depletion is shown. * indicates a statistically 
significant increased from empty vector (p value<0.05). B) ChIP‑qPCR 
with an antibody to H3K27me3 after Wapal depletion at two genomic 
elements, the c-Fos promoter and a combined Wapal/CTCF site approxi‑
mately 16kb downstream of the TSS. The genomic region is shown in 
Figure S3. * indicates statistically significant increase of empty vector 
over input (p value<0.05). + indicates statistically significant decrease of 
Wapal‑depleted samples from empty vector (p value<0.05).
Additional file 14: Table S3. Normalized microarray expression data.
Additional file 15: Table S4. List of all primers used.
Additional file 16: Table S2. List of datasets, total # of reads, and # of 
aligned reads used.
Page 17 of 18Stelloh et al. Epigenetics & Chromatin  (2016) 9:14 
maintenance of pluripotency gene expression in the absence of cohesin. 
Genes Dev. 2015;29:23–38.
 12. Cunningham MD, Gause M, Cheng Y, Noyes A, Dorsett D, Kennison JA, 
Kassis JA. Wapl antagonizes cohesin binding and promotes Polycomb‑
group silencing in Drosophila. Development. 2012;139:4172–9.
 13. Tedeschi A, Wutz G, Huet S, Jaritz M, Wuensche A, Schirghuber E, 
Davidson IF, Tang W, Cisneros DA, Bhaskara V, Nishiyama T, Vaziri A, Wutz 
A, Ellenberg J, Peters J‑M. Wapl is an essential regulator of chromatin 
structure and chromosome segregation. Nature. 2013;501:564–8.
 14. Boyle MI, Jespersgaard C, Brøndum‑Nielsen K, Bisgaard AM, Tümer Z. 
Cornelia de Lange syndrome. Clin Genet. 2015;88:1–12.
 15. Liu J, Krantz ID. Cornelia de Lange syndrome, cohesin, and beyond. Clin 
Genet. 2009;76:303–14.
 16. Cancer Genome Atlas Research Network. Genomic and epigenomic 
landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 
2013;368:2059–74.
 17. Thota S, Viny AD, Makishima H, Spitzer B, Radivoyevitch T, Przychodzen B, 
Sekeres MA, Levine RL, Maciejewski JP. Genetic alterations of the cohesin 
complex genes in myeloid malignancies. Blood. 2014;124:1790–8.
 18. Simon JA, Kingston RE. Occupying chromatin: polycomb mechanisms for 
getting to genomic targets, stopping transcriptional traffic, and staying 
put. Mol Cell. 2013;49:808–24.
 19. Woo CJ, Kharchenko PV, Daheron L, Park PJ, Kingston RE. A region of the 
human HOXD cluster that confers polycomb‑group responsiveness. Cell. 
2010;140:99–110.
 20. Zhao J, Ohsumi TK, Kung JT, Ogawa Y, Grau DJ, Sarma K, Song JJ, Kingston 
RE, Borowsky M, Lee JT. Genome‑wide identification of polycomb‑associ‑
ated RNAs by RIP‑seq. Mol Cell. 2010;40:939–53.
 21. Kaneko S, Son J, Shen SS, Reinberg D, Bonasio R. PRC2 binds active pro‑
moters and contacts nascent RNAs in embryonic stem cells. Nat Struct 
Mol Biol. 2013;20:1258–64.
 22. Li T, Hu J‑F, Qiu X, Ling J, Chen H, Wang S, Hou A, Vu TH, Hoffman AR. CTCF 
regulates allelic expression of Igf2 by orchestrating a promoter‑polycomb 
repressive complex 2 intrachromosomal loop. Mol Cell Biol. 2008;28:6473–82.
 23. Deng Z, Wang Z, Stong N, Plasschaert R, Moczan A, Chen H‑S, Hu S, Wikra‑
masinghe P, Davuluri RV, Bartolomei MS, Riethman H, Lieberman PM. A 
role for CTCF and cohesin in subtelomere chromatin organization, TERRA 
transcription, and telomere end protection. EMBO J. 2012;31:4165–78.
 24. Rao S, Zhen S, Roumiantsev S, McDonald LT, Yuan G‑C, Orkin SH. Differen‑
tial roles of Sall4 isoforms in embryonic stem cell pluripotency. Mol Cell 
Biol. 2010;30:5364–80.
 25. Pulakanti K, Pinello L, Stelloh C, Blinka S, Allred J, Milanovich S, Kiblawi 
S, Peterson J, Wang A, Yuan G‑C, Rao S. Enhancer transcribed RNAs arise 
from hypomethylated, Tet‑occupied genomic regions. Epigenetics. 
2013;8:1303–20.
 26. Lengner C, Camargo F, Hochedlinger K, Welstead G, Zaidi S, Gokhale 
S, Scholer H, Tomilin A, Jaenisch R. Oct4 expression is not required for 
mouse somatic stem cell self‑renewal. Cell Stem Cell. 2007;1:403–15.
 27. Yang H, Wang H, Shivalila CS, Cheng AW, Shi L, Jaenisch R. One‑step 
generation of mice carrying reporter and conditional alleles by CRISPR/
Cas‑mediated genome engineering. Cell. 2013;154:1370–9.
 28. Landt SG, Marinov GK, Kundaje A, Kheradpour P, Pauli F, Batzoglou S, 
Bernstein BE, Bickel P, Brown JB, Cayting P, Chen Y, DeSalvo G, Epstein C, 
Fisher‑Aylor KI, Euskirchen G, Gerstein M, Gertz J, Hartemink AJ, Hoffman 
MM, Iyer VR, Jung YL, Karmakar S, Kellis M, Kharchenko PV, Li Q, Liu T, 
Liu XS, Ma L, Milosavljevic A, Myers RM, et al. ChIP‑seq guidelines and 
practices of the ENCODE and modENCODE consortia. Genome Res. 
2012;22:1813–31.
 29. Wang J, Rao S, Chu J, Shen X, Levasseur DN, Theunissen TW, Orkin SH. A 
protein interaction network for pluripotency of embryonic stem cells. 
Nature. 2006;444:364–8.
 30. Wu N, Kong X, Ji Z, Zeng W, Potts PR, Yokomori K, Yu H. Scc1 sumoylation 
by Mms21 promotes sister chromatid recombination through counter‑
acting Wapl. Genes Dev. 2012;26:1473–85.
 31. Ong C‑T, Corces VG. CTCF: an architectural protein bridging genome 
topology and function. Nat Rev Genet. 2014;15:234–46.
 32. Phillips JE, Corces VG. CTCF: master weaver of the genome. Cell. 
2009;137:1194–211.
 33. Xiao T, Wallace J, Felsenfeld G. Specific sites in the C terminus of CTCF 
interact with the SA2 subunit of the cohesin complex and are required 
for cohesin‑dependent insulation activity. Mol Cell Biol. 2011;31:2174–83.
 34. Loh Y‑H, Wu Q, Chew J‑L, Vega VB, Zhang W, Chen X, Bourque G, George J, 
Leong B, Liu J, Wong K‑Y, Sung KW, Lee CWH, Zhao X‑D, Chiu K‑P, Lipovich 
L, Kuznetsov VA, Robson P, Stanton LW, Wei C‑L, Ruan Y, Lim B, Ng H‑H. 
The Oct4 and Nanog transcription network regulates pluripotency in 
mouse embryonic stem cells. Nat Genet. 2006;38:431–40.
 35. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette 
MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene 
set enrichment analysis: a knowledge‑based approach for inter‑
preting genome‑wide expression profiles. Proc Natl Acad Sci USA. 
2005;102:15545–50.
 36. Ben‑Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A, Weinberg 
RA. An embryonic stem cell‑like gene expression signature in poorly dif‑
ferentiated aggressive human tumors. Nat Genet. 2008;40:499–507.
 37. Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, Giannoukos G, Alvarez 
P, Brockman W, Kim T‑K, Koche RP, Lee W, Mendenhall E, O’Donovan A, 
Presser A, Russ C, Xie X, Meissner A, Wernig M, Jaenisch R, Nusbaum C, 
Lander ES, Bernstein BE. Genome‑wide maps of chromatin state in pluri‑
potent and lineage‑committed cells. Nature. 2007;448:553–60.
 38. Wong DJ, Liu H, Ridky TW, Cassarino D, Segal E, Chang HY. Module map of 
stem cell genes guides creation of epithelial cancer stem cells. Cell Stem 
Cell. 2008;2:333–44.
 39. Brookes E, de Santiago I, Hebenstreit D, Morris KJ, Carroll T, Xie SQ, Stock 
JK, Heidemann M, Eick D, Nozaki N, Kimura H, Ragoussis J, Teichmann 
SA, Pombo A. Polycomb associates genome‑wide with a specific RNA 
polymerase II variant, and regulates metabolic genes in ESCs. Cell Stem 
Cell. 2012;10:157–70.
 40. Liu Y, Shao Z, Yuan G‑C. Prediction of Polycomb target genes in mouse 
embryonic stem cells. Genomics. 2010;96:17–26.
 41. Wamstad JA, Alexander JM, Truty RM, Shrikumar A, Li F, Eilertson KE, Ding 
H, Wylie JN, Pico AR, Capra JA, Erwin G, Kattman SJ, Keller GM, Srivastava 
D, Levine SS, Pollard KS, Holloway AK, Boyer LA, Bruneau BG. Dynamic and 
coordinated epigenetic regulation of developmental transitions in the 
cardiac lineage. Cell. 2012;151:206–20.
 42. Schaaf CA, Misulovin Z, Gause M, Koenig A, Gohara DW, Watson A, 
Dorsett D. Cohesin and Polycomb proteins functionally interact to control 
transcription at silenced and active genes. PLoS Genet. 2013;9:e1003560.
 43. Vasanthi D, Nagabhushan A, Matharu NK, Mishra RK. A functionally 
conserved Polycomb response element from mouse HoxD complex 
responds to heterochromatin factors. Sci Rep. 2013;3:3011.
 44. Liang J, Lacroix L, Gamot A, Cuddapah S, Queille S, Lhoumaud P, Lepetit 
P, Martin PGP, Vogelmann J, Court F, Hennion M, Micas G, Urbach S, 
Bouchez O, Nöllmann M, Zhao K, Emberly E, Cuvier O. Chromatin immu‑
noprecipitation indirect peaks highlight long‑range interactions of insula‑
tor proteins and Pol II pausing. Mol Cell. 2014;53:672–81.
 45. Lin S, Ferguson‑Smith AC, Schultz RM, Bartolomei MS. Nonallelic tran‑
scriptional roles of CTCF and cohesins at imprinted loci. Mol Cell Biol. 
2011;31:3094–104.
 46. Xu M, Zhao G‑N, Lv X, Liu G, Wang LY, Hao D‑L, Wang J, Liu D‑P, Liang 
C‑C. CTCF controls HOXA cluster silencing and mediates PRC2‑repres‑
sive higher‑order chromatin structure in NT2/D1 cells. Mol Cell Biol. 
2014;34:3867–79.
 47. Narendra V, Rocha PP, An D, Raviram R, Skok JA, Mazzoni EO, Reinberg 
D. Transcription. CTCF establishes discrete functional chroma‑
tin domains at the Hox clusters during differentiation. Science. 
2015;347:1017–21.
 48. Noordermeer D, Leleu M, Splinter E, Rougemont J, De Laat W, Duboule D. 
The dynamic architecture of Hox gene clusters. Science. 2011;334:222–5.
 49. Noordermeer D, Leleu M, Schorderet P, Joye E, Chabaud F, Duboule D. 
Temporal dynamics and developmental memory of 3D chromatin archi‑
tecture at Hox gene loci. Elife. 2014;3:e02557.
 50. Liu J, Han Q, Peng T, Peng M, Wei B, Li D, Wang X, Yu S, Yang J, Cao S, 
Huang K, Hutchins AP, Liu H, Kuang J, Zhou Z, Chen J, Wu H, Guo L, Chen 
Y, Chen Y, Li X, Wu H, Liao B, He W, Song H, Yao H, Pan G, Chen J, Pei D. 
The oncogene c‑Jun impedes somatic cell reprogramming. Nat Cell Biol. 
2015;17:856–67.
 51. Nakajima M, Kumada K, Hatakeyama K, Noda T, Peters J‑M, Hirota T. The 
complete removal of cohesin from chromosome arms depends on 
separase. J Cell Sci. 2007;120:4188–96.
 52. Shen X, Kim W, Fujiwara Y, Simon MD, Liu Y, Mysliwiec MR, Yuan G‑C, Lee 
Y, Orkin SH. Jumonji modulates Polycomb activity and self‑renewal versus 
differentiation of stem cells. Cell. 2009;139:1303–14.
Page 18 of 18Stelloh et al. Epigenetics & Chromatin  (2016) 9:14 
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
 53. Denholtz M, Bonora G, Chronis C, Splinter E, De Laat W, Ernst J, Pellegrini 
M, Plath K. Long‑range chromatin contacts in embryonic stem cells 
reveal a role for pluripotency factors and polycomb proteins in genome 
organization. Cell Stem Cell. 2013;13:602–16.
 54. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, Fry B, 
Meissner A, Wernig M, Plath K, Jaenisch R, Wagschal A, Feil R, Schreiber 
SL, Lander ES. A bivalent chromatin structure marks key developmental 
genes in embryonic stem cells. Cell. 2006;125:315–26.
 55. Ku M, Koche RP, Rheinbay E, Mendenhall EM, Endoh M, Mikkelsen TS, 
Presser A, Nusbaum C, Xie X, Chi AS, Adli M, Kasif S, Ptaszek LM, Cowan 
CA, Lander ES, Koseki H, Bernstein BE. Genomewide analysis of PRC1 and 
PRC2 occupancy identifies two classes of bivalent domains. PLoS Genet. 
2008;4:e1000242.
 56. Kaneko S, Son J, Bonasio R, Shen SS. Nascent RNA interaction keeps PRC2 
activity poised and in check. Genes Dev. 2014;28:1983–8.
 57. Vernimmen D, Lynch MD, De Gobbi M, Garrick D, Sharpe JA, Sloane‑
Stanley JA, Smith AJH, Higgs DR. Polycomb eviction as a new distant 
enhancer function. Genes Dev. 2011;25:1583–8.
 58. van de Werken HJG, de Vree PJP, Splinter E, Holwerda SJB, Klous P, de 
Wit E, De Laat W. 4C technology: protocols and data analysis. Methods 
Enzymol. 2012;513:89–112.
 59. Dorsett D, Kassis JA. Checks and balances between cohesin minire‑
view and Polycomb in gene silencing and transcription. Curr Biol. 
2014;24:R535–9.
 60. Dorsett D, Merkenschlager M. Cohesin at active genes: a unifying theme 
for cohesin and gene expression from model organisms to humans. Curr 
Opin Cell Biol. 2013;25:327–33.
 61. Strübbe G, Popp C, Schmidt A, Pauli A, Ringrose L, Beisel C, Paro R. 
Polycomb purification by in vivo biotinylation tagging reveals cohesin 
and Trithorax group proteins as interaction partners. Proc Natl Acad Sci. 
2011;108:5572–7.
 62. Peric‑Hupkes D, van Steensel B. Linking cohesin to gene regulation. Cell. 
2008;132:925–8.
 63. Parelho V, Hadjur S, Spivakov M, Leleu M, Sauer S, Gregson HC, Jarmuz 
A, Canzonetta C, Webster Z, Nesterova T, Cobb BS, Yokomori K, Dillon N, 
Aragon L, Fisher AG, Merkenschlager M. Cohesins functionally associate 
with CTCF on mammalian chromosome arms. Cell. 2008;132:422–33.
 64. Karch F. In vivo studies of the Drosophila insulator factor CTCF reach a 
Catch 22. BMC Biol. 2015;13:1–3.
 65. Schwartz YB, Linder‑Basso D, Kharchenko PV, Tolstorukov MY, Kim M, 
Li H‑B, Gorchakov AA, Minoda A, Shanower G, Alekseyenko AA, Riddle 
NC, Jung YL, Gu T, Plachetka A, Elgin SCR, Kuroda MI, Park PJ, Savitsky M, 
Karpen GH, Pirrotta V. Nature and function of insulator protein binding 
sites in the Drosophila genome. Genome Res. 2012;22:2188–98.
 66. Milanovich S, Peterson J, Allred J, Stelloh C, Rajasekaran K, Fisher 
J, Duncan SA, Malarkannan S, Rao S. Sall4 overexpression blocks 
murine hematopoiesis in a dose‑dependent manner. Exp Hematol. 
2015;43(53–64):e1–8.
 67. Nelson JD, Denisenko O, Bomsztyk K. Protocol for the fast chromatin 
immunoprecipitation (ChIP) method. Nat Protoc. 2006;1:179–85.
 68. Aubert J, Dunstan H, Chambers I, Smith A. Functional gene screening in 
embryonic stem cells implicates Wnt antagonism in neural differentia‑
tion. Nat Biotechnol. 2002;20:1240–5.
 69. Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, 
Marraffini LA, Zhang F. Multiplex genome engineering using CRISPR/Cas 
systems. Science. 2013;339:819–23.
 70. Langmead B, Salzberg SL. Fast gapped‑read alignment with Bowtie 2. Nat 
Methods. 2012;9:357–9.
 71. Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, 
Nussbaum C, Myers RM, Brown M, Li W, Liu XS. Model‑based analysis of 
ChIP‑Seq (MACS). Genome Biol. 2008;9:R137.
 72. Ji H, Jiang H, Ma W, Johnson DS, Myers RM, Wong WH. An integrated soft‑
ware system for analyzing ChIP‑chip and ChIP‑seq data. Nat Biotechnol. 
2008;26:1293–300.
 73. Pinello L, Xu J, Orkin SH, Yuan G‑C. Analysis of chromatin‑state plasticity 
identifies cell‑type‑specific regulators of H3K27me3 patterns. Proc Natl 
Acad Sci. 2014;111:E344–53.
 74. Irizarry RA, Hobbs B, Collin F, Beazer‑Barclay YD, Antonellis KJ, Scherf U, 
Speed TP. Exploration, normalization, and summaries of high density 
oligonucleotide array probe level data. Biostatistics. 2003;4:249–64.
 75. Reich M, Liefeld T, Gould J, Lerner J, Tamayo P, Mesirov JP. GenePattern 2.0. 
Nat Genet. 2006;38:500–1.
 76. Hagège H, Klous P, Braem C, Splinter E, Dekker J, Cathala G, De Laat W, 
Forné T. Quantitative analysis of chromosome conformation capture 
assays (3C‑qPCR). Nat Protoc. 2007;2:1722–33.
